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Peptide modification of purified gellan gum 
 
C. J. Ferris,† a,b L. R. Stevens,† a,b K. J. Gilmore,a E. Mume,c I. Greguric,c D. M. Kirchmajer,a,b G. G. Wallacea,* 
and M. in het Panhuisa,b *  
Gellan gum (GG) is an anionic polysaccharide with potential as a biopolymer for additive manufacturing (3D-bioprinting) and 
tissue engineering. Previous studies have shown GG to be highly cytocompatible, but lacking specific attachment sites required 
for anchorage-dependent cells. In this work, we modify purified-GG polymer with a short peptide containing the arginine-
glycine-aspartic acid (RGD) sequence that is known to enhance integrin-mediated cell attachment. Radiolabelling of the peptide 
was used in optimisation of the conjugation procedure to achieve an overall efficiency of 40%. The purification of divalent 
cations from commercial GG samples was found to be critical for successful conjugation. Rheological studies revealed that the 
peptide coupling did not prevent gelation behaviour. C2C12 cells showed improved attachment on the surface of and 
encapsulated within RGD-GG hydrogels, differentiating to multinucleated myofibers after 5-7 days. PC12 cells showed 
minimal interactions with both GG and RGD-GG, with formation of cell clusters and impedance of terminal differentiation and 
neurite extension.  
	  
Introduction 
The use of biopolymers that mimic the extracellular matrix to 
form scaffolds for cell culture is a well-established technique 
that has been employed over several decades. The more recent 
developments in additive manufacturing (or biofabrication), 
particularly 3D-bioprinting, have paved the way for the 
formation of complex tissue structures by layering cells and 
biomaterials in a spatially controlled manner1. In many cases 
however, biomaterials that are optimised for processing do not 
support cellular interactions and vice versa2. Most cell types are 
anchorage-dependent, and must anchor to a suitable substrate in 
order to facilitate normal behaviour3, 4. The creation of new 
materials that combine the support of correct cell behaviour 
with versatile processability will be key to realising the 
potential of biofabrication.  
 Gellan gum (GG) is an anionic polysaccharide comprised of 
a repeating tetramer, with one carboxylate functionality per 
repeat unit 5. The structural and functional similarities between 
GG and the widely used alginate have helped identify it as a 
prime candidate for tissue engineering applications. The current 
uses and future potential of GG has been the focus of reviews in 
20005 and 20136, 7 and several studies have demonstrated the 
processability and versatility of GG7-9. In particular, GG has 
been employed as a material for bio-printing of cells and cell-
scaffolding structures 10-12. The biocompatibility of GG has also 
been probed. Rat bone marrow cells8, rabbit articular cartilage 
cells13 and human chondrocytes9 have all survived in GG, 
however these cell types are attachment-independent. Studies 
utilising anchorage-dependent cell lines have shown that GG is 
not an instructive cell encapsulation matrix. For example, 
fibroblasts14 and oligodendrocytes15 photo-encapsulated in 
methacrylated GG hydrogels maintained a non-responsive 
phenotype and showed reduced viability after several days in 
culture. Similar results have been obtained for analogous 
polysaccharide gel systems, with cardiomyocytes encapsulated 
in chitosan hydrogels16 and endothelial cells encapsulated in 
alginate17 showing a lack of cell adhesion. These results make it 
apparent that modification of GG hydrogels is required to 
support the adhesion, growth and normal function of 
anchorage-dependent cells.  
 The blending of complete proteins with polysaccharides is a 
popular approach for addressing this issue, as they contain the 
biofunctionality native to the extracellular matrix (ECM). 
Polysaccharides including alginate18, 19, chitosan20 and 
hyaluronic acid21 have all been blended with collagen and/or 
laminin to create composite hydrogels that encourage the 
attachment and growth of encapsulated cells. Alternatively, 
polysaccharides may be directly functionalised to produce 
materials that combine both processability and cellular 
attachment sites. The tri-peptide sequence arginine-glycine-
aspartic acid (RGD) has been identified as the cell attachment 
site in many ECM proteins and is pivotal to integrin-mediated 
cell binding22, 23. This peptide, and other similar sequences, 
have been widely utilised to modify polymer biofunctionality24. 
One of the most common applications of this approach is the 
conjugation of RGD peptides to alginate25. Other research in 
this area involves modification of alginate with the peptide 
G4RGDY, including a 6-month implantation study with a rat 
model, which showed good vascularisation and tissue 
integration in vivo26. The potential of RGD-alginates for 
injectable systems by delivering endothelial cells encapsulated 
in RGD-modified alginate in vitro has also been reported17, 
while the potential of peptide-modified alginates for spinal cord 
repair has been demonstrated27. Human fibroblasts28 and 
adipose derived stem cells29 have also been incorporated into 
	  
	  
peptide-modified alginate gels. More recently, furan 
functionalisation of GG, followed by a Diels-Alder reaction 
with a synthetic variant of the GRDGS peptide was used to 
direct neural and mesenchymal stem cell differentiation with 
encouraging results30, 31.  
 In this paper, we covalently linked unmodified peptides to 
GG, and monitored the reaction efficiency by tyrosine 
radiolabelling. The impact of RGD modification on GG’s 
physical properties and cell interaction are presented.  
 
 
Experimental 
Gellan gum purification 
All materials were obtained from Sigma, unless specifically 
stated otherwise. Commercial samples of low-acyl GG obtained 
from CP Kelco (traded as Gelzan™ CM) were purified to 
remove divalent cation using an established method32-34. A 1% 
(w/v) GG solution was formed by dissolving Gelzan™ CM (0.5 
g) in 50 mL of hot Milli-Q water (60 °C, resistivity 18.2 MΩ 
cm). 1.25 g of Dowex 50W-X8 cation exchange resin (Fluka, 
H+ form, 50-100 mesh), pre-rinsed in 1 M HCl and Milli-Q 
water, was then added and the hot mixture was stirred for 30 
min to convert GG to the free acid form (gellanoic acid). The 
resin was allowed to settle and the supernatant decanted into a 
pre-heated beaker through a coarse filter. The resin was rinsed 
twice with small volumes of 60 °C water and added to the 
supernatant. To this solution (kept at ~ 60 °C), 4 M NaOH was 
added dropwise until the pH stabilised at ~ 7.5 to convert the 
gellanoic acid to the sodium salt (sodium gellanate, NaGG). 
After stirring for an additional 5 min, 100 mL of 2-propanol 
was added with continued stirring to precipitate a white fibrous 
product. This product was vacuum filtered, washed with 2-
propanol and dried under vacuum overnight before being 
chopped into a fine powder and stored under cool, dry 
conditions until required.  
Atomic absorption spectroscopy 
The concentration of Na, Ca, K and Mg in GG and NaGG was 
determined using flame atomic absorption spectroscopy (AAS) 
burning acetylene/air. Samples were analysed using a Spectra 
AA 220FS (Varian) spectrometer equipped with sodium (589.6 
nm), potassium (769.9 nm), calcium (422.7 nm) and 
magnesium (285.2 nm) hollow cathode lamp sources. Samples 
were prepared by digesting 1 g of dry material in 5 mL of hot 
concentrated sulphuric acid (Ajax Finechem), followed by 
dropwise addition of hydrogen peroxide (30% (v/v), Ajax 
Finechem) until the solution became transparent. The solution 
was allowed to cool prior to the addition of 16 mL of 12.6 
mg/mL caesium chloride ionisation suppressant.  The solution 
was then made up to 100 mL with the addition of Milli-Q H2O 
and mixed thoroughly prior to measurement. Concentrations 
were blank-corrected and interpolated from calibration curves 
prepared using a certified multi-element standard solution 
(Inorganic Ventures). The limit of detection for each element 
was taken as twice the standard deviation of blank 
measurements. 
RGD conjugation reaction 
Peptides were coupled to NaGG using a wide variety of 
conditions. Under optimal conditions, 100 mg of NaGG was 
dissolved in a premade 50 mM solution of 2-(N-
morpholino)ethanesulfonic acid (MES) buffer (pH 6.5) by 
stirring at ~60 °C to yield 10 mL of a 1 % (w/v) NaGG 
solution. In a separate vial, 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC, Sigma) was added under N2 gas and 
dissolved in MES buffer to yield a solution of 0.3 M EDC, 50 
µL of which was immediately transferred to the NaGG solution. 
50 µL of a 0.15 M solution of N-hydroxysulfosuccinimide 
(sulfo-NHS) in MES buffer was added to the reaction vessel. 
The solution was then vortexed and allowed to activate at 37 °C 
for 15 mins (Figure 1: Reactions 1,2). After activation, 
G4RGDSY and G4RGESY peptide (Auspep) solutions were 
added in sufficient quantity to bind to 1 mol% of total 
carboxylate groups and the mixtures (RGD-GG and RGE-GG, 
respectively) were retained overnight at 37 °C (Figure 1: 
reaction 3). A third mixture (GG/RGD) was prepared using a 
NaGG solution without addition of EDC, but coupled with 1 
mol% G4RGDSY. 
 After reaction, solutions were purified by dialysis against 
Milli-Q water over 5 days using Slide-a-Lyzer mini dialysis 
devices (0.1 mL, MWCO 10 kDa, ThermoScientific). The 
dialysed product was lyophilised for 2 days and then stored 
under cool (4 °C), dry (sealed in flask) conditions prior to use. 
 
 
Figure 1: Reaction scheme for the peptide modification of purified GG, 
performed in three-steps: (1) EDC activation of the carboxylate on the 
GG backbone forming an unstable intermediate; (2) sulfo-NHS 
stabilisation of the reactive intermediate; and (3) peptide coupling to the 
GG backbone and regeneration of sulfo-NHS. 
	  
	  
 
Radiolabelling to determine conjugation efficiency 
For quantitative analysis of peptide binding to purified GG, the 
peptide G4RGDSY was radiolabelled through radio-iodination 
of the tyrosine residue using the well-established chloramine-T 
method35.  Iodine-125 carrier free radionuclide was purchased 
from Perkin-Elmer (Na125I, t1/2 = 59.4 days, NEZ033H010MC). 
50 µL of a 1 mg/mL solution of G4RGDSY in Milli-Q water 
was diluted with 180 µL of 0.1 M sodium phosphate buffer (pH 
6.0). A 50 µL aliquot of Na125I (diluted 1:50 in 1 mM NaOH) 
was added, followed by 10 µL of 1 mg/mL chloramine-T in 
buffer. After 5 min, the reaction was quenched by the addition 
of 10 µL of sodium metabisulfite (Merck) at 2.5 mg/mL in 
buffer. The reaction mixture (300 µL total) was loaded onto an 
Oasis HLB SPE cartridge (Waters) that had been pre-
equilibrated by eluting 5 mL methanol, 5 mL water and 10 mL 
0.1% trifluoroacetic acid (TFA) in water (solvent A). The 
cartridge was then washed with 20 mL of solvent A to remove 
unbound iodine-125. Two fractions were eluted, the first with 4 
mL of a 1:1 mixture of solvent A with 0.1% TFA in acetonitrile 
(solvent B), and the second with 4 mL of solvent B. The two 
fractions were pooled, dried in a rotary evaporator and re-
dissolved in Milli-Q water (350 µL).  
 The concentration and purity of the radiolabelled peptide 
was confirmed by radio-HPLC analysis using a Shimadzu 
HPLC-DAD system equipped with an In/Us Systems gamma 
ram detector and an Eclipse XDB-C18 column (Agilent, 
250x4.6 mm) with 5 µm particle size. Compounds were eluted 
using 30% (v/v) acetonitrile and water at a flow rate of 1 
mL/min, isocratic, over 15 min. Peptide concentration was 
calculated using a calibration curve constructed from HPLC 
chromatograms of G4RGDSY solutions of known 
concentration, plotting integrated peak area (λ = 254 nm) as a 
function of peptide concentration  
 Radiolabelled peptides were then coupled to NaGG as 
described above. Reaction products were separated using Zeba 
spin desalting columns (0.5 mL, MWCO 40 kDa, 50 °C 
ThermoScientific) to remove unconjugated peptide and other 
small reaction species from the peptide-conjugated NaGG. The 
radioactivity in all components of the system (i.e. sample, 
filtrates, eluates, dialysates, separation devices) was measured 
using a Perkin Elmer 2480 WIZARD2 gamma counter and 
converted to specific activity by calibration against known 
samples of 125I-G4RGDSY. Conjugation efficiencies reported 
here are the ratios of specific activity in NaGG bound peptides, 
to the total activity recorded across all components. 
Rheology 
The rheological characteristics of GG, NaGG and RGD-GG 
hydrogels were investigated using an Anton Paar Physica MCR 
301 rheometer equipped with a temperature controlled mantle 
and base plate. 1% (w/v) solutions of commercial GG, purified 
NaGG and modified RDG-GG were formed in Milli-Q water 
by stirring overnight at 50 °C. Viscosity was measured between 
0.1 and 100 1/s shear rate at 37 °C. 
 The 1% (w/v) polymer solutions and two solutions of CaCl2 
with concentrations of 1% (w/v) and 0.9% (w/v), respectively 
were placed in a water bath at 80 °C. Receiving wells were 
formed from pre-cut cylinders of polyvinyl chloride (PVC) with 
internal diameter of 18 mm and height of 5 mm, which were 
placed in Petri dishes and sealed around the base with silicon 
sealant. 4.5 mL of each hot polymer solution was then mixed 
with 500 µL of CaCl2 solution to yield final Ca2+ and polymer 
concentrations of 9 mM and 0.9% (w/v) respectively. NaGG 
and RGD-GG were mixed with 1% (w/v) CaCl2, whilst 
commercial GG received 0.9% (w/v) CaCl2 to adjust for the 
Ca2+ content already present in the material as determined by 
AAS (Table 1). Immediately after mixing, these solutions were 
pipetted into the PVC moulds and allowed to gel at 4 °C for 1 
h. Once formed, hydrogels were transferred to the rheometer 
and equilibrated to 37 °C. Each hydrogel was slightly 
compressed using a 15 mm stainless steel parallel plate and 
tested under oscillating shear, with the strain amplitude rising 
from 0.01% to 100% shear strain at a constant angular 
frequency of 5 Hz.  
Cell response 
The phenotypic cell response to RGD-GG was assessed with 
the anchorage-dependent murine skeletal muscle C2C12 cell 
line and the neuronal rat pheochromocytoma PC12 cell line, 
both obtained from the American Type Culture Collection 
(ATCC). For surface seeding experiments, 0.15% (w/v) 
solutions of GG, GG/RGD, RGE-GG and RGD-GG were 
pipetted into 96-well plates and gelled by the slow addition of 
concentrated Dulbecco's Modified Eagle's Medium (DMEM, 
Invitrogen) down the wall of the well. Hydrogels were then 
formed at 37 °C and equilibrated over 1 h using two changes of 
cell proliferation media (CPM), specifically DMEM 
(Invitrogen) supplemented with 10% (v/v) foetal bovine serum 
(FBS, Invitrogen) for C2C12 cells, and DMEM with 5% (v/v) 
FBS and 10% (v/v) horse serum for PC12 cells. Cells were 
seeded at 5000 cells/well and incubated at 37 °C and 5% (v/v) 
CO2 with media changes every 2 days. Cell morphology was 
assessed daily using bright field microscopy, and cell viability 
was assessed using calcein AM (Molecular Probes, Life 
Technologies) and propidium iodide (PI) staining and 
fluorescence imaging for up to 6 days in culture. Differentiation 
was induced by switching to low serum media, i.e. DMEM with 
2% (v/v) horse serum for C2C12 cells and DMEM with 1% 
(v/v) horse serum and 50 ng/mL nerve growth factor (NGF, 
Life Technologies) for PC12 cells. Differentiating cells were 
cultured for up to 6 days with media changes every 2 days. 
 Immunostaining was used to characterise the phenotype of 
differentiated C2C12 and PC12 cells. For C2C12 cells, staining 
targeted desmin, a sarcomeric intermediate filament protein 
expressed in skeletal muscle. For PC12 cells, staining targeted 
β-III tubulin, a globular microtubule protein expressed 
exclusively in neurons. In each case, cell nuclei were counter-
	  
	  
stained using 4’,6-diamidino-2-phenylindole (DAPI, 1 µg/mL), 
which binds strongly to DNA. Differentiated cells were fixed 
with 3.7% paraformaldehyde (PF, Fluka) in phosphate buffered 
saline (PBS) for 10 minutes at room temperature (21 °C, RT) 
and stored in PBS containing calcium and magnesium (DPBS) 
at 4° C prior to staining.  
 For staining of C2C12 cultures, cells were permeabilised 
with 50:50 methanol:acetone on ice for 5 minutes and washed 
with DPBS before blocking in 10% donkey serum (DS, 
Chemicon) with 0.05% Tween-20 (Sigma) for 1 hr at 21°C. 
Mouse monoclonal anti-desmin primary antibody (Novocastra) 
was diluted 1:100 in blocking solution and incubated at 4°C 
overnight. After two 10 min washes in DPBS, cells were 
incubated for 1 hr at 25˚C in the dark with the secondary 
antibody Alexa-546 donkey anti-mouse (Invitrogen) diluted 
1:1000 in blocking solution. After two 10 min washes in DPBS, 
DAPI (Molecular Probes) was added at 1:1000 in DPBS for 5 
min at 21 °C, before replacing with fresh DPBS and imaging 
using a Zeiss Axiovert inverted fluorescence microscope. For 
staining of PC12 cells, the same protocol was followed, 
however the primary antibody (anti-b-tubulin, Covance) was 
diluted 1:1000. Incubation times for all immunostaining 
reagants were doubled when cells were encapsulated in 
hydrogels rather than surface seeded. 
 For cell encapsulation studies sucrose was used to protect 
cells from any potential osmotic injury resulting from exposure 
to the hypotonic GG solution before addition of culture media. 
A GG solution at twice the desired final concentration was 
combined with an equal volume of a 20% (w/v) sucrose 
solution. This working solution was then used to resuspend 
cells that had previously been washed and suspended in 10% 
(w/v) sucrose at 5 x 105 – 2 x 106 cells/mL and pipetted into 96-
well plates. CPM containing 5 mM CaCl2 was then slowly 
added down the side of each well to crosslink the GG-cell 
suspensions. Media was changed twice over a period of 1 hr 
using CPM without additional CaCl2, and cells were maintained 
and monitored over time in culture with media changes every 
48 h. 
 MTS assays (Promega Corp.) were conducted according to 
the manufacturer’s protocol on encapsulated C2C12 and PC12 
cell cultures proliferating for periods up to 72 hr in NaGG and 
RGD-GG hydrogels at a polymer concentration of 0.15% (w/v). 
 
Results and discussion 
Gellan gum purification 
The concentrations of major monovalent (Na+, K+) and divalent 
(Ca2+, Mg2+) cations in as-received (commercial) GG and 
purified NaGG were measured by atomic absorption 
spectroscopy (Table 1). Commercial samples of GG are 
predominantly in the potassium salt form, with lesser amounts 
of Na+, Ca2+ and Mg2+ as the other major cations. The measured 
concentrations of divalent cations in commercial gellan gum 
were sufficient to neutralize around one-third of the carboxylate 
groups in GG, reducing their availability for reaction with 
EDC, and therefore the peptide.  
 To negate this impact, we purified our commercial GG 
samples (following a published procedure32-34) to remove 
divalent cations and yield monovalent cation salts. The product, 
sodium gellanate (NaGG), was a white fibrous product at ~ 
60% yield by weight (Figure 2). The concentration of Na+ in 
NaGG was equivalent to ~ 72.5 mol% of carboxyl groups. 
Hence, substantial percentages of the carboxylate sites were 
available for peptide coupling using the purified product. 
Additionally, In 2005, Ogawa et al. reported NaGG shifts from 
a random coil to a helixed state between 30-35˚C 36. This 
transition is a key process in GG gellation and implies that 
NaGG will resist gellation at physiological temperature (37˚C) 
until divalent cations are added. The reduced prevelance of 
premature gellation allowed for thee dissolution of higher 
concentrations of GG at physiological temperatures, providing 
an additional avenue for improving the reaction efficiency in 
EDC-mediated peptide conjugation.  
 
Table 1: Concentration of major cations present in as-received 
(commercial) gellan gum (GG) and purified sodium gellanate (NaGG), 
measured by atomic absorption spectroscopy. 
 
Element  
(% w/w) Na
+ K+ Ca2+ Mg2+ 
GG 0.6 ± 0.1 4.5 ± 0.2 1.2 ± 0.1 0.11 ± 0.01 
NaGG 2.5 ± 0.1 1.0 ± 0.1 < 0.06 < 0.03 
 
Figure 2: Gellan gum (GG) through each stage of processing. From left to 
right, as-received (commercial) GG powder, lyophilised NaGG, lyophilised 
RGD-GG and a 0.9% (w/v) RGD-GG hydrogel. 
Peptide conjugation to purified GG 
Conjugation reactions with NaGG were performed under a 
range of conditions including variations to peptide, NaGG, 
EDC and sulfo-NHS concentrations, temperature, and reaction 
buffer (Table 2, Figure 3). Conjugation of 0.1% (w/v) NaGG 
solutions yielded an efficiency (~ 19%) which was significantly 
higher than those obtained using commercial GG (<5%, see the 
Electronic Supporting Information) under the same conditions.  
 This clearly indicates that the removal of divalent cation 
(present in commercial GG) significantly enhanced the 
conjugation efficiency without any additional optimisation of 
the reaction. The purification process also afforded better 
	  
	  
control of the gellation process of GG, and enabled conjugation 
reactions using more concentrated 0.5% (w/v) and 1.0% (w/v) 
NaGG solutions, yielding efficiencies of around 35%. 
 Based on the data (Table 2, Figure 3) obtained through 
radiolabelling, selection of buffer, pH and adequate 
concentrations of EDC and GG appear to be the primary 
determinants of conjugation efficiency. MES buffer at pH 6.5 
was found to significantly out-perform the other tested systems, 
however the same buffer at pH 5 yielded no significant peptide 
conjugation. These results suggest that a pH of 6.5 achieved a 
balance between the reactivity of the EDC, the terminal amine 
of the peptide and the carboxyl group on the polymer, a finding 
similar to results obtained for alginate.25.  
 A pH of 6.5 strikes a balance between EDC’s peak 
reactivity at pH ~4.5, and that of the terminal amine, which is 
strongly activated at pH 8-924. The GG pKa value of 3.06 
implies that a pH of 6.5 promotes dissociation in over 99.9% of 
available carboxylate residues37. However, despite the similar 
pH value (6.7) the sodium acetate buffer impeded RGD peptide 
coupling, possibly due to de-activation of EDC by nucleophilic 
attack from acetate ions38, underscoring the importance of 
appropriate buffer selection.  
 
 
 
Table 2: Reaction efficiencies for the EDC-mediated conjugation of 
G4RGDSY to NaGG under varying reaction conditions. Reaction 
efficiencies were determined by gamma counting of conjugated and 
radio-labelled G4RGDSY after separation of unbound peptide by spin 
desalting. 
 
NaGG 
(% 
w/v) 
EDC 
(%COOH) 
G4RGDSY 
(%COOH ) 
Temp 
(˚C) 
Buffer 
 
Efficiency 
(% ±1 STD) 
1 20 2 37 
MES pH 
6.5 37.0 ± 1.0 
1 20 0.2 37 
MES pH 
6.5 37.8 ± 3.0 
1 20 0.02 37 
MES pH 
6.5 30.9 ± 3.1 
1 10 2 37 
MES pH 
6.5 33.3 ± 2.8 
1 5 2 37 
MES pH 
6.5 24.4 ± 3.1 
1 20 2 21 
MES pH 6.5 35.2 
± 0.3 
1 20 2 60 
MES pH 6.5 26.9 
± 2.3 
1 0 2 37 
MES pH 6.5 9.7 ± 
0.6 
0.5 20 2 37 
MES pH 6.5 35.3 
± 0.4 
0.1 20 2 37 
MES pH 6.5 18.7 
± 0.7 
1 20 2 37 MES pH 5.0 
9.92 
± 0.8 
1 20 2 37 
Na3PO4 pH 
8.0 
15.1 
± 0.3 
1 20 2 37 
NaC2H3O2 
pH 6.7 
13.7 
± 1.1 
1 20 2 37 
Milli-Q 
H2O 
11.8 
± 0.8 
Figure 3: Peptide (G4RGDSY) conjugation efficiencies as determined after 
HPLC by gamma counting of radio-labelled iodine on the terminal tyrosine 
of the G4RGDSY peptide. Efficiencies were compared in terms of separation 
method (A), NaGG concentration (B), EDC concentration (C), peptide 
concentration (D), reaction temperature (E) and buffer selection (F). Blue 
shaded data indicate the conditions that were carried across to the other 
reactions shown, white bars indicate the additional tested conditions. Red 
bars in (A) represent control reactions with no added EDC. Error bars 
represent 1 standard deviation of the mean. 
The EDC concentration was varied from 0-20 mol% of 
available carboxylate groups, with reaction efficiencies rising 
four fold over that range. This result is similar to that 
previously observed for alginate25, i.e. peak efficiency at an 
EDC concentration of 10% of available carboxylate groups. 
EDC concentrations above 20% were not employed to 
minimise a previously reported side reaction in which the active 
ester undergoes internal rearrangement and incorporates into 
	  
	  
the product25, 39. It is suggested that in the absence of EDC, the 
apparent conjugation efficiency of 10% can be attributed to the 
presence of unbound RGD peptide (remaining after a single 
spin-desalting step). Thorough purification by five-day dialysis 
was observed to better separate unbound peptide (Figure 3A). 
Ambient (21 ˚C) and physiological (37 ˚C) temperatures 
were found to promote conjugation equally well (Figure 3E). 
However elevated temperatures (~60 ˚C) were found to reduce 
conjugation efficiency. It is likely that this is related to a trade-
off between reaction kinetics of EDC coupling and the 
availability of carboxyl groups for activation. The input 
concentration of G4RGDSY peptide (when varied over 3 orders 
of magnitude) was not observed to significantly alter the overall 
conjugation efficiency (Figure 3D).  
These results suggest that RGD-peptide density could be 
tailored to suit a wide variety of extracellular environments. 
The density of RGD peptides presented to cells has been shown 
to affect a range of cellular responses including attachment, 
spreading, proliferation and differentiation24, 40-42.  
The highest efficiency for conjugation of G4RGDSY to 
NaGG achieved in this work (~ 40%) was lower than that 
observed by for the conjugation of GRGDY to alginate (> 80%) 
25. The lower efficiency could be due to the use of a longer 
peptide sequence. This is supported by a subsequent report 
demonstrating that a longer peptide G4RGDY conjugated to 
alginate resulted in a decrease in efficiency to 55%42.  
For our work, we chose to use an RGD-containing peptide 
with a poly-glycine tail due to evidence from several studies 
indicating the need for a spacer that separates the RGD 
sequence from the material to which it is conjugated, enhancing 
its availability to cellular integrins24. The required length of this 
spacer, or the need for one at all, is largely dependent upon the 
structure of the host material. We were therefore guided by 
work characterising the effect of glycine tail length on the 
response of human fibroblast cells to RGD-modified alginate 
hydrogels28.  In this report, it was shown that a minimum spacer 
length of four glycine units was required to facilitate the 
development of focal adhesions, cell proliferation and a 
reduction in cell stress markers. The apparent trade-off between 
reaction efficiency, optimal with short peptides, and cellular 
response, favouring longer peptides, is an observation that 
warrants investigation with respect to all RGD-modified 
polymers. 
Impact of RGD-modification on the rheological behaviour 
of GG 
One of the key benefits of GG as a biomaterial is its mechanical 
and rheological behaviour. Specifically, GG forms self-
supporting hydrogels under physiologically relevant conditions, 
but flows freely when no divalent cations are present 43. This 
behaviour is mediated by inter-chain helix formation, which is 
stabilised by the ionic bridging of neighbouring carboxylate 
residues by cations, particularly Ca2+ 44. Modification of GG, 
particularly when involving the carboxylate groups, has the 
potential to disrupt this behaviour. Rheological testing was 
performed to quantify the impact of peptide modification on the 
physical properties of GG. The flow curves of the solutions of 
as-received GG and its derivatives (prior to crosslinking) 
showed that as-received GG exhibited higher apparent viscosity 
values compared with purified NaGG and RGD-GG (Figure S1, 
the Electronic Supporting Information, ESI). 
 Oscillating shear dynamic mechanical analysis was 
performed on hydrogels of 0.9% (w/v) as-received GG with 9 
µM CaCl2 (Figure 4). Storage modulus (G’) and loss modulus 
(G”) are measures of the elastic and viscous behaviours of non-
Newtonian materials, respectively. All tested hydrogels 
exhibited linear viscoelastic (LVE) regions in which G’ and G” 
were invariant with strain. The dominance of G’ over G” in this 
region is indicative of fully formed, pseudo-solid hydrogels.  
 The significant reduction in G’ and G” values for RGD-GG 
compared to NaGG indicates a generalised weakening of inter-
chain interactions has resulted from the peptide modification 
reaction. The magnitude of this effect is notable given that only 
~1 mol% of available carboxylate residues were modified with 
G4RGDSY, yet the reduction in G’ and G” was between 1-2 
orders of magnitude. This suggests that the peptide alters GG 
rheological characteristics in a manner that cannot be singularly 
explained by a reduced availability of carboxylate groups. We 
propose that the bulky peptide hinders the formation of inter-
chain helicies between adjacent GG chains, which typically 
precedes ionic cross-linking43. Importantly, the rheological 
characterisation has demonstrated that peptide conjugation does  
not prevent gellan gum’s gelation behaviour that is so critical to 
many applications in tissue engineering and additive 
manufacturing (although weaker gels are formed).  
 
Table 3: Linear viscoelastic (LVE) region in terms of storage (G’) and 
loss (G”) moduli of hydrogels formed from commercial (GG), purifed 
(NaGG) and RGD-modified (RGD-GG) gellan gum. The end point of 
the LVE reported here is taken to be the onset of a sustained rise in the 
loss modulus, typically around 0.5% strain. 
 
	   GG NaGG RGD-GG 
LVE G’ 
(kPa) 105 ± 35.3 85.9 ± 6.0 5.64 ± 0.37 
LVE G” 
(kPa) 10.0 ± 0.32 4.5 ± 1.3 0.37 ± 0.15 
End LVE 
(Strain %) 0.21 ± 0.06 0.35 ± 0.12 0.82 ± 0.51 
 
	  
	  
 
Figure 4: Oscillatory shear rheometry, sweeping shear strains from 0.01-
100% at 37˚C. Tests were performed on 10 mm x 17 mm hydrogel cylinders 
comprising 9 mM CaCl2 and 0.9% (w/v) of A: commercial GG, B: purified 
NaGG and C: peptide modified RGD-GG.  
 
Cell response to peptide-modified gellan gum 
We investigated the response of two cell lines to RGD-GG, the 
murine skeletal muscle C2C12 cell line which is anchorage-
dependent, and the rat pheochromocytoma PC12 cell line, 
which exists as both adherent and suspended populations in 
standard tissue culture on polystyrene. After initial optimisation 
of the concentration of NaGG for cell surface seeding, these 
cells were seeded both on the surface of, and encapsulated 
within, 0.15% (w/v) NaGG and 0.15% (w/v) RGD-GG 
hydrogels with the peptide coupled at 0.1 mol% and 1 mol% of 
available carboxyl groups, denoted as RGD-GG(0.1%) and 
RGD-GG(1.0%). The RGD-peptide concentration in the latter 
hydrogels is approximately 9 µmol/L, with an effective surface 
availability of approximately 4.5 fmol/cm2, calculated using the 
established methods42,24. 
 In order to rule out that any changes to cell response could 
be due to changes in the physical characteristics of the hydrogel 
rather than as a result of specific integrin-mediated interactions 
with the RGD peptide, control samples of NaGG were 
conjugated with the peptide G4RGESY at 1 mol%, denoted 
RGE-GG(1%). The RGE sequence differs chemically from the 
RGD sequence by only one –CH2 group, however this minor 
change has a significant effect on its integrin affinity, which is 
several orders of magnitude lower than for RGD45. An 
additional hydrogel control sample was prepared using a 
mixture of NaGG (without added EDC) and 1 mol%  
G4RGDSY, denoted GG/RGD. As the RGD is not conjugated, 
but non-specifically bound to GG, there is a lower amount of 
peptide remaining due to the dialysis procedure (Figure 3A).  
 Figure 5 shows cells seeded on the surface of 0.15% (w/v) 
RGD-GG hydrogels and 0.15% (w/v) NaGG controls after 24 h 
in culture. Cells on unmodified NaGG surfaces formed large 
aggregates typical of poor adhesion to the substrates. Cells 
formed similar aggregates on RGE-GG(1%) indicating that 
conjugation of this non-integrin-targeting sequence did not 
modify cell attachment to the surface. On GG/RGD, the 
hydrogel containing non-specifically bound peptide, cell 
aggregates were smaller but there was little evidence of cell 
spreading.  
 On the surface of RGD-GG(1%) hydrogels however, 
C2C12 cells were observed to rapidly attach, and few large cell 
clusters were observed. After 24 h of culture, C2C12 cells 
exhibited a typically flattened and elongated morphology, 
indicating the development of strong cell adhesions and 
implicating specific integrin-mediated interaction. C2C12 cell 
attachment was dependent on RGD density, as cells seeded on 
hydrogels with a lower concentration of RGD peptide, RGD-
GG(0.1%), adopted a rounded morphology or formed small 
aggregates with few flattened and elongated cells (Figure 5E). 
PC12 cells retained rounded morphologies typical of this cell 
line under proliferation conditions (data not shown). 
 C2C12 cells encapsulated in peptide-modified and control 
hydrogels (Figure 5F-J) showed a similar range of responses to 
those seeded on corresponding hydrogel surfaces. Cells in 
NaGG maintained a rounded morphology reflective of a lack of 
adhesive interactions (Figure 5F). A similar response was 
observed for cells encapsulated in RGE-GG(1%) (Figure 5G) 
and GG/RGD (Figure 5H) hydrogels, in agreement with 
surface-seeded results. RGD-GG(1%) hydrogels, however, 
supported the attachment and proliferation of encapsulated 
C2C12 cells (Figure 5I). This effect was observed to a lesser 
extent for the lower peptide density hydrogel formed using 
RGD-GG(0.1%) (Figure 5J). PC12 cells, in contrast, showed 
minimal change in morphology resulting from the presence of 
RGD, with the majority of cells remaining in clusters 
independent of the presence of RGD-peptide (Figure S2, ESI). 
	  
	  
 
 
Figure 5: C2C12 cells seeded on the surface of (A-E) and encapsulated 
within (F-J) 0.15% (w/v) hydrogels after 24 h under proliferation 
conditions. Hydrogels were formed from unmodified NaGG (A, F), 
RGE-GG(1%) (B, G), GG/RGD (C,H), RGD-GG(1%) (D, I), RGD-
GG(0.1%) (E, J). Scale bars represent 50 µm.  
 
Both C2C12 and PC12 cells were observed to proliferate when 
surface seeded or encapsulated within the RGD-GG(1.0%) gels. 
MTS assays were used to quantify changes in the cellular 
metabolic activity of encapsulated cells, which can be related to 
changes in cell number or activity within the cell population. 
MTS assays applied to GG encapsulated PC12 and C2C12 cells 
showed that the overall metabolic activity was greater for cells 
encapsulated in 0.15% (w/v) RGD-GG(1.0%) hydrogels than in 
the equivalent NaGG hydrogels.  
 For PC12 cells there was a consistent increase in metabolic 
activity over a 72 h period that reflected the observed 
proliferation of encapsulated cells (Figure 6A). For C2C12 
cells, the increase in metabolic activity was consistently 
delayed (Figure 6B). However, at alltime points the cellular 
metabolic activity in RGD-GG(1.0%) gels was higher than that 
in the corresponding NaGG gels, indicating that the RGD 
peptide afforded a better growth environment to both of the cell 
lines over a 72 h culture period.  
 
 
 
 
Figure 6: MTS assays for encapsulated PC12 (A) and C2C12 (B) cells 
under proliferative conditions over a 72 h period. Grey and black bars 
indicate 0.15% (w/v) hydrogels formed using RGD-GG(1.0%) and 
NaGG, respectively. The increased metabolic activity in cells 
encapsulated in RGD-GG was statistically significant at the **99% or 
*97% confidence level (Student’s T test). 
 
Both encapsulated and surface-seeded cells were induced to 
differentiate by exposure to low serum conditions. After only 
12 h, C2C12 cells on the surface of RGD-GG had formed into 
large multi-cellular fibres and aggregates, and this contraction 
continued with further culture. C2C12 cells cultured on 
polystyrene take up to 6 days to differentiate, however early 
differentiation has previously been observed for C2C12 cells on 
the surface of RGD-alginate hydrogels25. This was attributed to 
the compliant nature of the hydrogel substrate, and could be the 
reason for the rapid cell response observed in the current work. 
After 5 days incubation under differentiation conditions, 
fixed and immunostained samples showed formation of 
multinucleated myofibres, typical of differentiated skeletal 
muscle (Figure 7A). Encapsulated C2C12 cells were also found 
to differentiate into multinucleated skeletal muscle fibres within 
RGD-GG(1.0%) hydrogels (Figure 7B-C), in contrast to the cell 
behaviour observed within gels prepared without the peptide 
(Figure 7D). The extent of multinuclear fibre formation was 
found to be dependant on the encapsulated cell density, i.e. at 
higher cells density (2x106 cells/mL) a higher percentage of 
cells were incorporated into fibres than at lower density 
(0.5x106 cells/mL). This behaviour corresponds to the observed 
role of skeletal muscle cell density culture. 
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Figure 7: (A) Surface seeded and (B, C) encapsulated C2C12 cells after 5 
days of culture in 0.15% (w/v) RGD-GG(1.0%) hydrogels under 
differentiation conditions. (D) Encapsulated C2C12 cells after 5 days of 
culture in 0.15% (w/v) NaGG hydrogels under differentiation conditions. 
Cells were immunostained for the skeletal muscle protein desmin (red) and 
nuclei stained with DAPI (blue). Scale bars represent 50 µm.  
 
In contrast, assessing the differentiation of PC12 cells within 
RGD-GG(1.0%) and NaGG hydrogels was problematic as cells 
readily clustered in both materials. Neurite extension was 
observed only for single cells or very small clusters (Figure S2, 
ESI). Differentiation from larger cell clusters was impeded, 
suggesting that the RGD density and/or GG concentration may 
need to be further optimised for this cell type to achieve 
improved cell differentiation. Our results for PC12 cells are in 
agreement with previous studies on RGD-functionalised cell 
culture plastic surfaces that showed that PC12 cells exhibited 
enhancement in proliferation without significant morphological 
changes46, 47. More recent work however has identified an 
important role in local microstructure for controlling cell 
behaviour48, and PC12 and C2C12 cells on RGD-modified 
surfaces showed differing behaviour depending on the 
microstructure employed 49, 50. In a similar manner, the local 
density of RGD sites appears to play a significant role in 
controlling the behaviour of attached cells41,42. In addition, 
mechanical properties are known to impact cell behaviour 51, 
and the fusion of C2C12 cells into myofibres has been shown to 
be dependent on the mechanical properties of their 
environment52. 
 In summary, we observed adhesion, spreading, proliferation 
and differentiation into multinucleated fibres for C2C12 cells, 
however PC12 cells showed enhancement only in overall 
metabolic activity, broadly in line with previous findings41, 42, 46, 
47. Realising the potential of any material for tissue engineering 
inevitably relies on tailoring its mechanical and biochemical 
properties to match that of the target tissue. The tuneable 
mechanical properties of GG 53, 54, and capacity for peptide 
functionalisation, make it an excellent candidate for this role.   
 
Conclusions 
We have presented a covalent modification procedure for the 
conjugation of short peptides to gellan gum. Purification of GG 
was essential for successful conjugation, and optimisation of 
coupling conditions resulted in a conjugation efficiency of 
~40%. Rheological studies indicated that the attachment of 
RGD to the carboxyl residues does not impede the formation of 
hydrogels, although mechanical weaker gels are formed.  
 C2C12 and PC12 cell lines proliferated when seeded on the 
surface and encapsulated into the gels and the increase in 
overall cellular metabolic activity in RGD-GG hydrogels was 
quantitated by MTS assay. The differentiation of the C2C12 
cell line was enhanced by the RGD-peptide for both surface 
seeded and encapsulated cells, resulting in multinucleated 
skeletal muscle fibres either on the gel surface or throughout 
the bulk of RGD-GG hydrogels.   
 This paper provides a reliable method for the 
functionalisation of GG with short peptide sequences, with the 
covalent linkage of G4RGDSY found to produce a significant 
improvement to the cell attachment properties of GG. It is 
anticipated that the reported enhancement in cell interactions 
will increase the use of GG as a cell scaffolding biomaterial for 
tissue engineering and a bio-ink for additive manufacturing 
(3D-bioprinting). 
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